AUPS337802A0 - Method of screening for antidiabetic agents - Google Patents

Method of screening for antidiabetic agents

Info

Publication number
AUPS337802A0
AUPS337802A0 AUPS3378A AUPS337802A AUPS337802A0 AU PS337802 A0 AUPS337802 A0 AU PS337802A0 AU PS3378 A AUPS3378 A AU PS3378A AU PS337802 A AUPS337802 A AU PS337802A AU PS337802 A0 AUPS337802 A0 AU PS337802A0
Authority
AU
Australia
Prior art keywords
screening
antidiabetic agents
antidiabetic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPS3378A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPS3378A priority Critical patent/AUPS337802A0/en
Publication of AUPS337802A0 publication Critical patent/AUPS337802A0/en
Priority to PCT/JP2003/008523 priority patent/WO2004005550A2/en
Priority to AU2003245051A priority patent/AU2003245051A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPS3378A 2002-07-04 2002-07-04 Method of screening for antidiabetic agents Abandoned AUPS337802A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPS3378A AUPS337802A0 (en) 2002-07-04 2002-07-04 Method of screening for antidiabetic agents
PCT/JP2003/008523 WO2004005550A2 (en) 2002-07-04 2003-07-04 Method of screening for antidiabetic agents
AU2003245051A AU2003245051A1 (en) 2002-07-04 2003-07-04 Method of screening for antidiabetic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPS3378A AUPS337802A0 (en) 2002-07-04 2002-07-04 Method of screening for antidiabetic agents

Publications (1)

Publication Number Publication Date
AUPS337802A0 true AUPS337802A0 (en) 2002-07-25

Family

ID=3836934

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPS3378A Abandoned AUPS337802A0 (en) 2002-07-04 2002-07-04 Method of screening for antidiabetic agents

Country Status (2)

Country Link
AU (1) AUPS337802A0 (en)
WO (1) WO2004005550A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863275B1 (en) * 2003-12-09 2007-08-10 Biomerieux Sa METHOD FOR THE DIAGNOSIS / PROGNOSIS OF BREAST CANCER
GB2436837A (en) * 2006-04-05 2007-10-10 Univ Open Culturing adipocytes
WO2008035309A2 (en) * 2006-09-21 2008-03-27 Piramal Life Sciences Limited Method for identifying compounds that act as insulin-sensitizers
WO2008134727A1 (en) * 2007-04-30 2008-11-06 The Board Of Regents Of The University Of Texas System Methods and compositions for treatment of reperfusion injury and other cardiac conditions
CN105445472A (en) * 2015-11-13 2016-03-30 泰山医学院 Method and kit for detecting activity of micro-molecular G protein Rap1
CN107353205B (en) * 2017-07-27 2020-02-07 中国科学院新疆理化技术研究所 Ester compound in nigella glandulifera Freyn seeds as well as preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2386750A1 (en) * 1999-10-22 2001-05-03 Merck & Co. Inc. Pharmaceuticals for treating obesity

Also Published As

Publication number Publication date
WO2004005550A2 (en) 2004-01-15
WO2004005550A3 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AU2003277596A1 (en) Method of deuterization
AU2003269126A1 (en) Method of combining materials
AU2003277663A1 (en) Screening method
AU2002249467A1 (en) Screening method
AUPS096002A0 (en) Method of construction
AU2003242340A1 (en) Novel screening method
AUPS337802A0 (en) Method of screening for antidiabetic agents
AU2002247215A1 (en) Method for screening compounds
AU2003254579A1 (en) Methods of screening for schizophrenia
AU2003227268A1 (en) Novel screening method
AU2003253813A1 (en) Method for colpoplasty
AU2003202622A1 (en) A method of screening
AU2003285503A1 (en) Screening method
AU2003245051A1 (en) Method of screening for antidiabetic agents
AU2003251156A1 (en) Screening for anti-ovulatory compounds
AU2003242342A1 (en) Novel screening method
AU2002952966A0 (en) Screening apparatus
AU2003217008A1 (en) Screening method
AU2002354247A1 (en) Screening method
AU2003248955A1 (en) Screening method
AU2003235310A1 (en) Novel screening method
AU2003210099A1 (en) New method
AU2003244107A1 (en) Methods of searching for substance having antidiabetic effect
AU2003241904A1 (en) Novel method of screening
AU2002952433A0 (en) Screening method